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ated the immune response against viral infection by enhancing the expression of many 
interferon-inducible genes that were activated by adenovirus carry!ng ~-gal gene com- 
pared to the mock treatment. 
Conclusion: These data show that Akt controls a genetic program that promotes the 
activation and survival of endothelial cells. Furthermore, these data provide a framework 
to understand how Akt signaling controls the blood vessel growth at a molecular level. 
1105-73 DNA Microarray Analysis of the Progressive 
Arterialization and Intimal Hyperplasia of Venous Grafts 
in a Canine Model 
Matthew D. Bacchetta. Ying Zhou, Ronda Chert, Sanjay A. Samy, Arash Salemi, Adam 
Hamawy, Lufei Hu, Karl H. Krieger, O. Wayne Isom, Wilson Ko, Daniel F. Catanzaro, 
New York Presbyterian Hospita/-Wei/I Medical College of Come//Universi~ New York, 
New York. 
Intimal hyperplasia of arterialized venous grafts is a leading cause of coronary artery 
bypass graft (CABG) failure. DNA array analysis of tissue RNA provides a means to 
identify genes involved in this process. DNA arrays are unavailable for the dog, which is 
used as a model for CABG surgery. This study evaluated the use of a heterologous DNA 
array (rat) to measure RNA in vein grafts from dogs. Mongrel dogs underwent bilateral 
carotid venous interposition grafts and left internal mammary artery (LIMA) graft to a cor- 
onary artery. Samples of the grafts were collected for histologic and RNA analyses at 3-, 
10-, and 30-days (n=4 per time point). RNA levels were measured using heterologous 
cDNA microarrays(Affymetrix~ rat U34). Each animal served as its own control using a 
vein sample saved at the initial surgery. Gene expression was analyzed using dChip soft- 
ware, Among the 8,784 genes represented in the probe set, 8,8-10% were assessed as 
present in the venous mRNA samples. Although lower than the percentage present when 
RNA was analyzed with GeneChips~ of the corresponding species (25-40% for rat vas- 
cular tissue in our lab), the levels were highly consistent across samples. Significant' 
changes were found in mRNA levels in arterialized venous grafts for 63 genes (>2-fold, 
p<0.05). Hierarchical clustering revealed four patterns of gene expression: (1) early stim- 
ulation (3 days) followed by suppression (10 & 30 days) (4 genes), (2) early and sus- 
tained stimulation (27 genes), (3) early and sustained suppression (36 genes), and (4) 
mid point stimulation (10 days) flanked by early and late suppression (6 genes). The fold 
change in mRNA levels ranged from -25 to +20-fold. In addition to known structural (e. g. 
actin, collagen, fibronectin) and regulatory proteins(fos), a number of novel ESTs were 
also identified. Histological findings (e. g. collagen deposition and smooth muscle hyper- 
plasia) were consistent with changes observed in gene expression, This study demon- 
strates the feasibility of using heterologous (rat) gene chips to analyze the progression of 
intimal hyperplasia in artedalizing canine vein grafts. It also identified possible molecular 
targets for gene therapy or pharmaceuticals to improve graft life. 
1105-74 Prof i l ing Gene Expression in Atherosclerosis Using 
DNA Microarrays 
Kavitha M Chinnaivan, Arun Sreekumar, Waiter M. Whitehouse, Jr., Naresh T. 
Gunaratnam, Stuart A. Winston, Arul M. Chinnaiyan, Saint Joseph Mercy Hospital, Ann 
Arbor, Michigan, University of Michigan, Ann Arbor, Michigan. 
Background. Atherosclerosis (AS) and its sequelae account for high morbidity and mor- 
tality in the U.S. Defining the genes responsible for growth, stability or rupture of the ath- 
erosclerotic plaque can aid in understanding its pathogenesis and designing therapies. 
While traditional approaches focus on one gene at a time, cDNA microarray technology 
provides a "global" perspective. 
Methods. Plaque specimens were collected from routine carotid endarterectomies. Tiny 
portions of normal adjacent endothelium taken from each patient provided comparison. 
Control was non-atherosclerotic artery obtained at autopsy, Total RNA extracted from 
samples was used to generate fluorascently labeled cDNA probes using reverse tran- 
scdptase. The probes were hybridized to a high-density, 10K human oDNA microarray ( 
DNA "chip") comprised of > 4,500 known human genes + > 5000 expressed sequence 
tags (ESTs). Gene expression data deposited into a relational database was analyzed. 
Hierarchical clustering of data and visualization using the Traeview program defined 
coordinated patterns of gene expression. Genes differentially expressed were validated 
by RT-PCR. 
Results, >130 genes differentially expressed in plaques relative to normal arterial tissue 
were identified. Complete concordance was obtained between microarray data and RT- 
PCR for 18 genes tested. Many genes were previously implicated in AS (e.g., VCAM-1) 
forming independent validation for our study. Importantly, genes not previously implicated 
in AS were identified, including OB-Cadherin-ll, Cadherin 13, Herin, Cathepsin O, Kal- 
1, RBM3 TNR3, LIM7, IGF*2, IGFBP5 and OSF-2. The cluster of 130 genes was classi- 
fied into distinct functional groups, including call adhesion and extracellular matrix com- 
ponents, transcription factors, enzymes, complement and MHC, growth factors, kinase 
and phosphatase, free radical scavengers, glycoproteins and proteoglycans, and miscel- 
laneous. 
Conclusion. In this study, we delineated a cohort of novel genes significantly dysragu- 
lated in the human atherosclerotic plaque. Future studies are needed to define the func- 
tional role of these genes in the pathogenesis of AS and their potential as therapeutic 
targets. 
1105-75 Impairment of Neovascularization by Smoking: Role of 
HIF-lalpha and VEGF 
Soohie Elise Michaud, Catherine Menard, Louis-Georges Guy, Giuseppa Gennaro, Alain 
Rivard, University of Montreal, Notre-Dame Hospital Montreal Quebec, Canada. 
Background: Smoking is a major nsk factor for coronary and peripheral artery diseases. 
However, the impact of smoking on collateral vessel development has not been studied. 
Accordingly, we studied the effect of smoking on angiogenesis in the setting of vascular 
ischemia. Methods and Results: Hindlimb ischemia was created by femoral artery resec- 
tion in mice exposed to cigarefte smoke (MES, n=20) and control mice (n=2O). We found 
that smoking was associated with a significant reduction in blood flow recovery as 
assessed by laser Doppler flow ratio (LDFR) between the ischemic and the normal limb. At 
day 21 after surgery, MES had a LDFR of 0.60+0.11 vs 0.78_+0.07 for controls (p<0,001), 
and this impaired blood flow perfusion in MES was still present at day 28 after surgery 
(LDFR: 0.63_+0.03 vs 0.80_+0.03, p<0.001). CD31 immunostaining confirmed the laser Dop- 
pler data by showing a significant reduction in capillary density in the MES at day 28 after 
surgery (477_+34 capillaires/mm 2 vs 681+54 capillades/mm 2 in controls p<O.05). Western 
blot analysis of ischemic muscles demonstrated that smoking was associated with a signif- 
icant reduction in vascular endothelial growth factor (VEGF) expression at days 3, 7 and 14 
after surgery. Moreover, this reduced VEGF expression correlated with a significant reduc- 
tion in the expression (Western blot) and binding activity (electromobility shift assay) of the 
transcription factor HIF-lc~ in MES. Lower HIF-lc( binding activity and VEGF expression 
were also observed in vascular smooth muscle cells that were exposed to cigarette smoke 
extract in vitro. Importantly, rescue of HIF-le expression using an adenoviral gene delivery 
strategy resulted in a significant improvement of blood flow recovery in MES. Conclusion: 
1 ) Angiogenesis in ischemic vascular disease is impaired by smoking 2) This impairment in 
neovessel formation is due, at least in part, to the negative effect of smoking on HIF-lc( and 
VEGF expression under hypoxic conditions 3) Smoke-induced impairment of angiogenesis 
can be rescued by adeno-HIF gene therapy. 
1105-76 The Matrix Protein Bone Sialoprotein Enhances 
Calcification in Vascular Smooth Muscle Cells 
Lorraine A. Fitzoatrick. Sean Harrington, Tim O'Brien, Mayo Clinic, Rochester, 
Minnesota. 
Background: Matrix proteins are an integral component of the atherosclerotic plaque 
and regulate calcification. The role of these proteins in the calcification process is poorly 
understood. Vascular smooth muscle cells (VSMCs) are an integral part of the plaque 
and produce matrix proteins including osteopontin, osteocalcin, bone sialoprotein and 
type I collagen. The calcification within an atherosclemtic plaque is an active and regu- 
lated process with similarities to Ossification in bone. We explored the role of two matrix 
proteins that are associated with bone calcification, osteopontin (OPN) and bone sialo- 
protein (BSP). Methods: VSMCs were isolated from the coronary arteries of sexually 
mature pigs. For antisense experiments, oligonucleotides directed at OPN or BSP were 
made, utilizing the coding strand as a control. A replication defective adenovirus (AD) 
human serotype 5 was constructed with either OPN (AD-OPN), BSP (AD-BSP), or null 
(AD-NuII) inserts driven by a CMV promoter. VSMCs were infected and maintained in 
DMEM. VSMCs were fixed and stained for calcium using the Von Kossa method and 
nodules and calcium were quantified. Results: In nontransfected VSMCs, inhibition of 
BSP expression by oligonucleotides resulted in a decrease in calcified nodules while 
inhibition of OPN expression caused an increase in calcification. Electron micrographs 
confirmed the presence of calcium crystals, similar to those found in bone-forming ostao- 
blasts. To further evaluate the role of OPN and BSP, ceils were transfected with AD-BSP, 
AD-OPN or AD-NulI. There was a marked and significant increase in nodule calcification 
in VSMCs containing AD-BSP compared to AD-Null (P<0.02) or AD-OPN (P<0.00001). 
In contract, AD-OPN VSMCs revealed marked inhibition of calcified nodules compared to 
AD-BSP. Conclusion; VSMCs and matrix proteins are integral components of the ath- 
erosclerotic plaque. These findings suggest that bone sialoprotein and ostaopontin con- 
tribute to regulation and play an unique role in the calcification process during plaque 
development. 
1105-77 Evaluation of the Dynamics of Substance Delivery via 
Retrograde Perfusion of the Coronary ~°inus in Dogs 
With Acute and Chronic Cardiac Ischemia 
Eduard Fiehn. Wilfried Roethy, Anguo Gu, Kotaro Suehiro, Geng-Hua Yi, Jie Wang, 
Daniel Burkhoff, Columbia University - Division of Circulatory Physiology, Department of 
Medicine, New York Ci~ New York. 
Background: Coronary sinus (CS) ratroperfusion (R) is a potential way to deliver sub- 
stances to the myocardium, particularly in the setting of ischemia where arterial delivery 
may be limited. We determined optimal conditions to achieve preferential substance 
delivery to ischemio myocardium with minimal systemic appearance. 
Methods: Anesthetized dogs were instrumented for CS-R, Isohemia was induced 
acutely by LAD ligation (n=14) or chronically by ameroid constrictor (n=3) implanted 3 
weeks earlier. The CS was occluded and R performed for 10 min. Colored microspheres 
(MS) were injected into the CS and their ~ppearance in different regions of the heart and 
in the kidneys (to index systemic delivery) were quantified. The following parameters 
were varied: catheter position proximal in CS (n=6) vs distal in the great cardiac vein 
(n=8); perfusion with blood (n=6) vs crystalloids (n=8); low (5-20 ml/min) vs high (50-250 
ml/min) R flow. 
Results: During acute isohemia, more MS appeared in ischemic LAD tissue (arterial flow 
0.3±0.2 ml/min/g; 4297±2457 MS/g tissue) compared to non-ischemic LCx tissue (arte- 
rial flow 1.4±0.3 ml/min/g; 1058±456 MS/g tissue, p<.05). Distal catheter placement in 
combination with low-flow CS-R reduced the amount of MS shunted to the systemic cir- 
culation by 85% compared to proximal placement and high flow perfusion. With chronic 
LAD occlusion, resting flow was normal in LAD area (1.1±0.3 vs 0.9±0.2 ml/min/g in the 
LCx area) and CS-R did not provide preferential MS delivery (1133±691 vs 1946±1450 
MS/g in the LAD and LCx territories, respectively). 
Conclusion: CS-R leads to preferential substance delivery to acutely ischemic areas, 
but not in the setting of chronic LAD occlusion where resting antegrade blood flow is nor- 
mal. Systemic appearance of injected substances can be minimized using an optimized 
ratroperfusion protocol. These results will help guide understanding of whether it is 
advantageous to consider CS-R as a means of delivering a particular substance (e.g., 
drug, gene, growth factor, etc.) in a particular setting (normal, acute or chronic ischemia). 
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